7 results
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... level < 200 mg/dL Pathophysiology ... of EuDKA by Gillian ... EuDKA #diagnosis #management ... #endocrinology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Epidemiology: • 1-2 cases ... Pathophysiology ... CSF PROTEIN - NORMAL ... Syndrome #diagnosis #management
Diabetic Ketoacidosis (DKA) - Pathogenesis and Clinical Findings
 • Note: in DKA, body K+ is lost
Diabetic Ketoacidosis ... to be falsely normal ... DiabeticKetoacidosis #DKA #pathophysiology ... #endocrinology ... #diabetes
Ketosis Disorders
Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
Diabetic ketoacidosis ... (DKA) - caused ... Glucosuria causes ... differential #diagnosis #management ... #endocrinology
Diabetes Morning Hyperglycemia - Dawn Phenomenon vs Somogyi Effect 

When patients FBG's are elevated each morning
Diabetes Morning ... experiencing the normal ... insulin levels causes ... Hyperglycemia #Diagnosis #Management ... #Endocrinology
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... Incidence: 1 to 2 cases ... the underlying pathophysiology ... SinaiBmoreIMRes #GBS #Guillain ... Syndrome #diagnosis #management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... MI, stroke, DVT/ ... are usually near-normal ... Hydroxyurea + anticoagulation ... hematology #diagnosis #management